Abeona Therapeutics Inc (NASDAQ: ABEO) kicked off on Friday, down -5.31% from the previous trading day, before settling in for the closing price of $5.08. Over the past 52 weeks, ABEO has traded in a range of $3.93-$7.54.
A company in the Healthcare sector has jumped its sales by 47.21% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 173.66%. With a float of $45.68 million, this company’s outstanding shares have now reached $51.25 million.
In an organization with 136 employees, it is important to assess its efficiency.
Abeona Therapeutics Inc (ABEO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Abeona Therapeutics Inc is 10.91%, while institutional ownership is 66.14%. The most recent insider transaction that took place on Oct 16 ’25, was worth 1,366. In this transaction Chief Executive Officer of this company sold 249 shares at a rate of $5.49, taking the stock ownership to the 1,189,818 shares. Before that another transaction happened on Oct 16 ’25, when Company’s Officer proposed sale 249 for $5.49, making the entire transaction worth $1,366.
Abeona Therapeutics Inc (ABEO) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.31 earnings per share (EPS), higher than consensus estimate (set at -0.41) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 173.66% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Take a look at Abeona Therapeutics Inc’s (ABEO) current performance indicators. Last quarter, stock had a quick ratio of 6.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 616.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.63, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Let’s dig in a bit further. During the last 5-days, its volume was 2.58 million. That was better than the volume of 1.04 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.48%.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 0.36%, which indicates a significant decrease from 1.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.84, while its 200-day Moving Average is $5.78. However, in the short run, Abeona Therapeutics Inc’s stock first resistance to watch stands at $4.97. Second resistance stands at $5.12. The third major resistance level sits at $5.21. If the price goes on to break the first support level at $4.73, it is likely to go to the next support level at $4.64. Assuming the price breaks the second support level, the third support level stands at $4.49.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
The company with the Market Capitalisation of 246.65 million has total of 51,279K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -63,730 K annual income. Company’s last quarter sales were recorded 400 K and last quarter income was 108,830 K.
